Sam, excellent point. How can Amarin turn Lemons ( no stop ) into lemonade ? Here's a tongue in cheek example.
Press Release we'd like to see
"Amarin is pleased to report the R-I study which reached interim milestone was analyzed by an independent commission and following their assessment, it was found that the trial was not futile, that the trial continues to track as expected."
"Dr. Ketchum remarked: We are very encouraged by the DMC recommendations, and remind Physicians of the unusually strong safety profile. We are confident in Reduce It, that like the JELIS study, Vascepa will ultimately prove to be therapeutically significant in the treatment of Cardiovascular disease."
Disclaimer:
"Today Vascepa is only indicated for the treatment of very high triglycerides because the asshats at the FDA were too stupid and lazy to recognize the pleiotropic effects of high dose EPA despite countless citations sent to the FDA by Zumantu"
Of course, as established by the courts and agreed to by the FDA, Amarin is allowed under 1st Amendment rights to remind physicians that the cohort in JELIS most similar to those subjects in Reduce It (secondary prevention, high TG ) realized a 53% resection in MACE. Did you get this ? Ok, just checking This is considered by the courts to be truthful and non misleading.
If you prefer to be a Zombie Doc and make your patients wait two years to reap improved plaque reduction, improved endothelial function, reduced inflammation, improved fibrous cap, and lower APOC III, lower VLDC, less platelet adhesion, reduction in small lipoprotein particles, improved cognition processing, improved mitochondrial function, skin protection from UV, improved libido and lastly; improved effectiveness of Statin therapy by increased reduction of hydro peroxides
Then what more can we say that would change your mind?
How about $9 a month for all of the above ?
Oh, still not convinced ?
I thought so....
News 
Market Data 
Discover 
